{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:50:38Z","timestamp":1764784238444},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:00:00Z","timestamp":1558569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00345-019-02817-4","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T08:03:41Z","timestamp":1558598621000},"page":"287-292","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Managing complications of collagenase Clostridium histolyticum (CCH) injection"],"prefix":"10.1007","volume":"38","author":[{"given":"Garrick M.","family":"Greear","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Koprowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tung-Chin","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,23]]},"reference":[{"key":"2817_CR1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ et al (2015) Peyronie\u2019s disease: AUA guideline. J Urol 194:745\u2013753. \nhttps:\/\/doi.org\/10.1016\/j.juro.2015.05.098","journal-title":"J Urol"},{"key":"2817_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.sxmr.2017.03.005","volume":"6","author":"AT Gabrielson","year":"2018","unstructured":"Gabrielson AT, Spitz JT, Hellstrom WJG (2018) Collagenase Clostridium histolyticum in the treatment of urologic disease: current and future impact. Sex Med Rev 6:143\u2013156. \nhttps:\/\/doi.org\/10.1016\/j.sxmr.2017.03.005","journal-title":"Sex Med Rev"},{"key":"2817_CR3","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","volume":"187","author":"M Gelbard","year":"2012","unstructured":"Gelbard M, Lipshultz LI, Tursi J et al (2012) Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease. J Urol 187:2268\u20132274. \nhttps:\/\/doi.org\/10.1016\/j.juro.2012.01.032","journal-title":"J Urol"},{"key":"2817_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJG et al (2013) Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol 190:199\u2013207. \nhttps:\/\/doi.org\/10.1016\/j.juro.2013.01.087","journal-title":"J Urol"},{"key":"2817_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000444399","volume":"100","author":"F Migliorini","year":"2018","unstructured":"Migliorini F, Bianconi F, Bizzotto L et al (2018) Acute ischemia of the glans penis after circumcision treated with hyperbaric therapy and pentoxifylline: case report and revision of the literature. Urol Int 100:361\u2013363. \nhttps:\/\/doi.org\/10.1159\/000444399","journal-title":"Urol Int"},{"key":"2817_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/bju.13120","volume":"116","author":"CC Carson","year":"2015","unstructured":"Carson CC, Sadeghi-Nejad H, Tursi JP et al (2015) Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie\u2019s disease (PD). BJU Int 116:815\u2013822. \nhttps:\/\/doi.org\/10.1111\/bju.13120","journal-title":"BJU Int"},{"key":"2817_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/1753193414528843","volume":"40","author":"CA Peimer","year":"2014","unstructured":"Peimer CA, Wilbrand S, Gerber RA et al (2014) Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren\u2019s contracture. J Hand Surg (Eur Vol) 40:141\u2013149. \nhttps:\/\/doi.org\/10.1177\/1753193414528843","journal-title":"J Hand Surg (Eur Vol)"},{"key":"2817_CR8","first-page":"3688","volume":"20","author":"R Sanjuan-Cervero","year":"2016","unstructured":"Sanjuan-Cervero R, Poquet-Jornet JE, Carrera-Hueso FJ (2016) Toxic dermatitis secondary to treatment with collagenase Clostridium histolyticum for Dupuytren\u00b4s disease. Eur Rev Med Pharmacol Sci 20:3688\u20133691","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2817_CR9","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.jhsa.2015.06.099","volume":"40","author":"RG Gaston","year":"2015","unstructured":"Gaston RG, Larsen SE, Pess GM et al (2015) The efficacy and safety of concurrent collagenase Clostridium histolyticum injections for 2 dupuytren contractures in the same hand: a prospective, multicenter study. J Hand Surg 40:1963\u20131971. \nhttps:\/\/doi.org\/10.1016\/j.jhsa.2015.06.099","journal-title":"J Hand Surg"},{"key":"2817_CR10","doi-asserted-by":"publisher","first-page":"237.e9","DOI":"10.1016\/j.urology.2017.05.004","volume":"106","author":"WJG Hellstrom","year":"2017","unstructured":"Hellstrom WJG, Tan RBW, Liu G (2017) Safety profile of collagenase Clostridium histolyticum stratified by degree of penile curvature in patients with peyronie disease. Urology 106:237.e9\u2013237.e14. \nhttps:\/\/doi.org\/10.1016\/j.urology.2017.05.004","journal-title":"Urology"},{"key":"2817_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/ju.0000000000000032","volume":"15","author":"WJG Hellstrom","year":"2019","unstructured":"Hellstrom WJG, Tue Nguyen HM, Alzweri L et al (2019) Intralesional collagenase Clostridium histolyticum causes meaningful improvement in men with Peyronie\u2019s disease: results of a multi-institutional analysis. J Urol 15:8. \nhttps:\/\/doi.org\/10.1097\/ju.0000000000000032","journal-title":"J Urol"},{"key":"2817_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jsxm.2016.02.105","volume":"13","author":"FA Yafi","year":"2016","unstructured":"Yafi FA, Anaissie J, Zurawin J et al (2016) Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase Clostridium histolyticum for Peyronie\u2019s disease. J Sex Med 13:684\u2013689. \nhttps:\/\/doi.org\/10.1016\/j.jsxm.2016.02.105","journal-title":"J Sex Med"},{"key":"2817_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.sxmr.2017.07.011","volume":"6","author":"JA Beilan","year":"2018","unstructured":"Beilan JA, Wallen JJ, Baumgarten AS et al (2018) Intralesional injection of collagenase Clostridium histolyticum may increase the risk of late-onset penile fracture. Sex Med Rev 6:272\u2013278. \nhttps:\/\/doi.org\/10.1016\/j.sxmr.2017.07.011","journal-title":"Sex Med Rev"},{"key":"2817_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4081\/aiua.2018.2.143","volume":"90","author":"L Dell\u2019Atti","year":"2018","unstructured":"Dell\u2019Atti L, Scarcella S, Argalia G et al (2018) Rupture of the cavernous body diagnosed by contrast-enhanced ultrasound: presentation of a clinical case. Arch Ital Urol Androl 90:143\u2013144. \nhttps:\/\/doi.org\/10.4081\/aiua.2018.2.143","journal-title":"Arch Ital Urol Androl"},{"key":"2817_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.sxmr.2017.07.009","volume":"6","author":"M Falcone","year":"2018","unstructured":"Falcone M, Garaffa G, Castiglione F, Ralph DJ (2018) Current management of penile fracture: an up-to-date systematic review. Sex Med Rev 6:253\u2013260. \nhttps:\/\/doi.org\/10.1016\/j.sxmr.2017.07.009","journal-title":"Sex Med Rev"},{"key":"2817_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4111\/icu.2017.58.4.255","volume":"58","author":"E Saglam","year":"2017","unstructured":"Saglam E, Tarhan F, Hamarat MB et al (2017) Efficacy of magnetic resonance imaging for diagnosis of penile fracture: a controlled study. Investig Clin Urol 58:255\u2013260. \nhttps:\/\/doi.org\/10.4111\/icu.2017.58.4.255","journal-title":"Investig Clin Urol"},{"key":"2817_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.urology.2016.09.050","volume":"100","author":"J Anaissie","year":"2017","unstructured":"Anaissie J, Yafi FA, DeLay KJ et al (2017) Impact of number of cycles of collagenase Clostridium histolyticum on outcomes in patients with Peyronie\u2019s disease. Urology 100:125\u2013130. \nhttps:\/\/doi.org\/10.1016\/j.urology.2016.09.050","journal-title":"Urology"},{"key":"2817_CR18","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.juro.2015.10.065","volume":"195","author":"MJ Ziegelmann","year":"2016","unstructured":"Ziegelmann MJ, Viers BR, McAlvany KL et al (2016) Restoration of penile function and patient satisfaction with intralesional collagenase Clostridium histolyticum injection for Peyronie\u2019s disease. J Urol 195:1051\u20131056. \nhttps:\/\/doi.org\/10.1016\/j.juro.2015.10.065","journal-title":"J Urol"},{"key":"2817_CR19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/bju.13932","volume":"120","author":"A Abdel Raheem","year":"2017","unstructured":"Abdel Raheem A, Capece M, Kalejaiye O et al (2017) Safety and effectiveness of collagenase Clostridium histolyticum in the treatment of Peyronie\u2019s disease using a new modified shortened protocol. BJU Int 120:717\u2013723. \nhttps:\/\/doi.org\/10.1111\/bju.13932","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02817-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T23:10:53Z","timestamp":1590102653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02817-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2817"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02817-4","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,23]]},"assertion":[{"value":"4 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Hsieh is a consultant for Endo Pharmaceuticals. Drs. Greear and Koprowski have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"No identifying information was included that would necessitate informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}